Role of Vitamin D receptor gene in radiation-induced neoplastic transformation of human breast epithelial cell

Steroids

Volumn 68, Issue 7-8, 2003, Pages 621-627

  Roy, Debasish ^a   Calaf, Gloria ^a   Hei, Tom K ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Immunohistochemical imaging; Linear energy transfer (LET); VDR gene polymorphism

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN; ISOPROTEIN; VITAMIN D RECEPTOR;

ARTICLE; BREAST EPITHELIUM; CARCINOGENESIS; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; DIGESTION; EPITHELIUM CELL; EXON; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INTRON; IRRADIATION; LINEAR ENERGY TRANSFER; NEOPLASM; PROGNOSIS; RADIATION DOSE; SEQUENCE ANALYSIS; TUMOR CELL LINE; TUMOR MODEL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0041828289     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(03)00091-6     Document Type: Article

References (59)

1. 3. Biochem. J. 316:1996;361-371.
2. Holick M.F. Vitamin D: A millennium perspective. J. Cell Biochem. 88:2003;296-307.
3. McDonnell D.P., Mangelsdorf D.J., Pike J.W., Haussler M.R., O'Malley B.W. Molecular cloning of complementary DNA encoding the avian receptor for Vitamin D. Science (Washington, DC). 235:1987;1214-1217.
4. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R.et al. Cloning and expression of full-length cDNA encoding human Vitamin D receptor. Proc. Natl. Acad. Sci. U.S.A. 85:1988;3294-3298.
5. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Nguyen T.V., Sambrook P.N.et al. Prediction of bone density from Vitamin D receptor alleles. Nature (Lond.). 367:1994;284-287.
6. 3 on primary cultures of human prostatic cells. Cancer Res. 54:1994;805-810.
7. 3 inhibits the invasive potential of human breast cancer cells in vitro. Clin. Exp. Metastasis. 12:1994;195-202.
8. Feldman D., Skowronski R.J., Peehl D.M. Vitamin D and prostate cancer. Adv. Exp. Med. Biol. 375:1995;53-63.
9. 3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression. Oncogene. 19:2000;5091-5097.
10. 3 and its analogues on induction of apoptosis in breast cancer cells. J. Steroid Biochem. Mol. Biol. 58:1996;395-401.
11. 3 and their combination. Cancer Lett. 75:1993;35-39.
12. Colston K.W., Coombes R.C., Berger U. Possible role for Vitamin D in controlling breast cancer cell proliferation. Lancet. 1:1989;188-191.
13. Lazzaro G., Agadir A., Qing W., Poria M., Mehta R.R., Moriarty R.M.et al. Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with Vitamin D receptors. Eur. J. Cancer. 36(6):2000;780-786.
14. Buras R.R., Schumaker L.M., Davoodi F., Brenner R.V., Shabahang M., Nauta R.J.et al. Vitamin D receptors in breast cancer cells. Breast Cancer Res. Treat. 31(2-3):1994;191-202.
15. 3. Cancer Res. 47:1987;21-25.
16. Lokeshwar B.L., Schwartz G.G., Selzer M.G., Burnstein K.L., Zhuang S.H., Block N.L.et al. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-di-hydroxyvitamin D (calcitriol) and EB 1089. Cancer Epidemiol. Biomark Prev. 8:1999;241-248.
17. Christakos S., Dhawan P., Liu Y., Peng X., Porta A. New insights into the mechanisms of Vitamin D action. J. Cell Biochem. 88:2003;695-705.
18. Bouillon R., Cromphaut S.V., Carmeliet G. Intestinal calcium absorption: molecular Vitamin D mediated mechanisms. J. Cell Biochem. 88:2003;332-339.
19. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res. 55:1995;2822-2830.
20. 3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res. 54:1994;1458-1464.
21. 3 analogues and tamoxifen. Cancer Res. 54:1994;5711-5717.
22. 3 analogues in breast cancer cells. Cancer Res. 56(12):1996;2789-2794.
23. Grant W.B. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer. 94(1):2002;272-281.
24. Xie S.P., James S.Y., Colston K.W. Vitamin D derivatives inhibit the mitogenic effects of IGF-1 on MCF-7 human breast cancer cells. J. Endocrinol. 154:1997;495-504.
25. Yoneda T., Sasaki A., Mundy G.R. Osteolytic bone disease in breast cancer. Breast Cancer Res. Treat. 32:1994;73-84.
26. Kanis J.A. Bone and cancer. Pathophysiology and treatment of metastases. Bone. 17:1995;101S-105S.
27. Green S., Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 4:1988;309-314.
28. Zhu W.Y., Jones C.S., Kiss A., Matsukuma K., Amin S., DeLuca L.M. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp. Cell Res. 234:1997;293-299.
29. 3 leads to induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142-153.
30. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene. 11:1995;493-504.
31. 3 in HL60 cells. Cancer Res. 56:1996;264-267.
32. 3-treated HL60 cells. Cancer Res. 57:1997;2851-2855.
33. 3 receptor in breast carcinoma. J. Histochem. Cytochem. 46(11):1998;1335-1337.
34. Hei T.K., Piao C.Q., Willey J.C., Thomas S., Hall E.J. Malignant transformation of human bronchial epithelial cells by radon-simulated alpha-particles. Carcinogenesis. 15(3):1994;431-437.
35. Hall E.J., Hei T.K. Modulating factors in the expression of radiation-induced oncogenic transformation. Environ. Health Perspect. 88:1990;149-155. Review.
36. Calaf G., Hei T.K. Establishment of a radiation- and estrogen-induced breast cancer model. Carcinogenesis. 21(4):2000;769-776.
37. Soule H.D., Maloney T.M., Wolman S.R., Peterson W.D. Jr., Brenz R., McGrath C.M.et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:1990;6075-6086.
38. Calaf G., Russo J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis. 14(3):1993;483-492.
39. Calaf G., Russo J., Tait L., Estrada S., Alvarado M.E. Morphological phenotypes in neoplastic progression of human breast epithelial cells. J. Submicrosc. Cytol. Pathol. 32(1):2000a;83-96.
40. Calaf G., Hei T.K. Oncoprotein expression in human breast epithelial cells transformed by high-LET radiation. Int. J. Radiat. Biol. 77:2001;31-40.
41. Roy D., Calaf G.M., Hei T.K. Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-Ras mutation during radiation-induced neoplastic transformation of human breast epithelial cells. Int. J. Cancer. 103:2003;730-737.
42. Gross-Bellard M., Oudet P., Chambon P. Isolation of high molecular weight DNA from mammalian cells. Eur. J. Biochem. 36:1973;32-38.
43. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989.
44. Lundin A.C., Soderkvist P., Eriksson B., Bergman-Jungestrom M., Wingren S. South-east Sweden Breast Cancer Group. Association of breast cancer progression with a Vitamin D receptor gene polymorphism. Cancer Res. 59:1999;2332-2334.
45. Bretherton-Watt D., Wilson-Given R., Mansi J.L., Thomas V., Carter N., Colston K.W. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br. J. Cancer. 85(2):2001;171-175.
46. Krishnan A, Feldman D. Regulation of Vitamin D receptor abundance. In: Feldman D, Glorieux FH, Pike JW, editors. Vitamin D. New York: Academic Press; 1997. p. 179-200.
47. 3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation. Biol. Pharm. Bull. 24(3):2001;242-248.
48. Ziegler R., Kasperk C. Glucocorticoid-induced osteoporosis: prevention and treatment. Steroids. 63(5/6):1998;344-348.
49. 3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res. Treat. 67(2):2001;157-168.
50. Darwish H., DeLuca H.F. Recent advances in the molecular biology of vitamin action. Prog. Nucl. Acid Res. Mol. Biol. 53:1996;321-344.
51. 3 regulation of c-myc protooncogene transcription. J. Biol. Chem. 264:1989;19710-19715.
52. Roy D., Calaf G.M., Hei T.K. Profiling of differentially expressed genes induced by high linear energy transfer radiation in breast epithelial cells. Mol. Carcinog. 31(4):2001;192-203.
53. 3 receptors in T47D breast cancer cells. J. Steroid Biochem. Mol. Biol. 45:1993;257-263.
54. 3 receptor content during pregnancy and lactation. Mol. Cell Endocrinol. 60:1988;15-22.
55. Mehta R., Moriarty R., Mehta R., Penmasta R., Lazzaro G., Constantinou A.et al. Prevention of preneoplastic mammary lesion development by an novel Vitamin D analogue, 1α-hydroxyvitamin D5. J. Natl. Cancer Inst. 89:1997;212-218.
56. Mezzetti G., Monti M., Casolo L., Piccinini G., Moruzzi M. 1,25-Dihydroxycholecalciferol-dependent calcium uptake by mouse mammary gland in culture. Endocrinology. 122:1988;389-394.
57. Rachez C., Gamble M., Chang C.P., Atkins G.B., Lazar M.A., Freedman L.P. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell. Biol. 20:2000;2718-2726.
58. 3-mediated anti-tumor activity with dexamethasone. J. Natl. Cancer Inst. 90:1998;134-141.
59. Nagpal S., Lu J., Boehm M.F. Vitamin D analogs: mechanism of action and therapeutic applications. Curr. Med. Chem. 8(13):2001;1661-1679.